Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of "Moderate Buy" from Analysts : vimarsana.com

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]

Related Keywords

United States , Canada , America , Michael Crowley , Caxton Associates , Bio Rad Laboratories Inc , Citigroup , Lecap Asset Management Ltd , Investors Pty Ltd , Comerica Bank , Thompson Siegel Walmsley , Royal Bank , Bio Rad Laboratories , Get Free Report , Marketbeat Ratings , Rad Laboratories , Asset Management , Pty Ltd , Get Free , Life Science , Bio Rad Laboratories Daily , Nyse Bio , Bio , Medical , 09057220 , Ratings , Consensus ,